According to Raphael Rostenne, CTO of EyeCarePro, "anything that takes time" has the potential to frustrate patients, ...
Kansas, Tennessee, and Vermont expanded optometric scope in 2026, while vision plan reform and a proposed Medicare fee ...
The FDA approved Lucamzi (ranibizumab-blrz; Xbrane Biopharma), a biosimilar to Lucentis (ranibizumab; Genentech), for neovascular (wet) age-related macular degeneration (AMD) and ...
The meeting, which comes a year after the agency issued a complete response letter in October 2025,2 was held from 8:30 am-3 ...
What to take away on PBM, hormonal eye health, and GLP-1 receptor agonists from this year’s meeting.
This week’s top stories include pipeline updates in dry eye, retinitis pigmentosa, contact lens hygiene, and more.
Raphael Rostenne discusses what a good phone call looks like and contributes to successful patient interactions with host ...
The release noted that brepocitinib demonstrated consistent benefits in preventing treatment failure across key subgroups, ...
FDA grants orphan drug designation to oral OCT-980 for RHO-adRP, now in phase 1b/2 testing at US sites. The FDA granted ...
Drs Bryce St. Clair and Behrad Garmsiri explain how they build trust, improve health literacy, and destigmatize future ...
Amanda Nanasy, OD, discussed how sports can open the door to eye care for underserved athletes and what goes into her ...
Optometry Times delivers clinical news, practice insights, and research updates by optometrists for optometrists to advance care and patient outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results